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Rational prescribing requires that prescribers follow a stan-
dard process of prescribing in accordance with standard treat-
ment guidelines which enables a consistent, therapeutically
effective and economically efﬁcient use of drugs. (Chukwuani
et al., 2002). National treatment guidelines for malaria were
designed and published in 2005 through collaborative efforts
of the directorate of malaria control, WHO, technical core
group and professionals from teaching institutions in Pakistan
(Directorate of Malaria Control and WHO, 2005). The guide-
lines have been formulated through an extensive deliberation
and local research carried out by renowned professional, mal-
ariologists and clinicians (Directorate of Malaria Control and
WHO, 2005). But still most of the medical practitioners in
Pakistan like other developing countries, are inclined to prac-
tice their own protocols to treat malaria rather than adhering
to standard regimens (Nizamani et al., 2006; Meremikwu et al.,
2007; Onwujekwe et al., 2009). This study aimed to assess the
adherence of current prescribing practices with standard treat-
ment guidelines and the role of malaria control program in the
implementation of standard treatment guidelines for the treat-
ment of malaria in public and private tertiary healthcare facil-
ities in Pakistan. The WHO prescribing indicator form was
used to collect data regarding current prescribing practices
for the treatment of malaria. Keeping in view the federal
administrative and regulatory structure of the country and
due to location and operation of Malaria control program in
the capital city, two main cities of Pakistan namely Islamabad
(federal capital) and Rawalpindi (twin city) were selected for
the study. The prevalence of Plasmodium vivax is relatively
more in these two cities as being located in the province, Pun-
jab while cases of P. falciparum are more frequently seen inPeer review under responsibility of King Saud University.
Production and hosting by Elsevier
1319-0164 ª 2012 King Saud University. Production and hosting by Elsev
http://dx.doi.org/10.1016/j.jsps.2012.02.005Sindh, KPK and Baluchistan. A total of 600 malaria encoun-
ters thirty from each healthcare facility were recorded from all
the public and private tertiary healthcare facilities in Islama-
bad (national capital) and Rawalpindi (twin city) and tallied
with national standard treatment guidelines for malaria.
Semi-structured interviews were conducted with eight malaria
control program ofﬁcials, transcribed verbatim, translated into
English, veriﬁed and analyzed thematically for content by
experts.
Out of 600 encounters, diagnosis was written on 37.2%
(n= 226), of the prescriptions while results of Malarial Para-
site (MP) test was mentioned in only 9.2% (n= 55) of the
cases. Malaria was being treated empirically on the basis of
sign and symptoms. National standard treatment guidelines
clearly indicate that if the type of malaria is not conﬁrmed
the therapy should be started with chloroquine but in most
of the prescriptions artemether/lumefentrine and fansidar were
used which are the choice of drugs in the case of falciparum
and vivax respectively. Correct doses of anti-malarial drugs
were given in 10.2% (n= 61), of the cases while correct fre-
quency of anti-malarial drugs in 9% (n= 54), correct strength
of the drugs in 9% (n= 54) and correct duration of drugs in
9.2% (n= 55) of the cases respectively. On the other hand,
out of 600 encounters, in 29.1% (n= 175) of the cases antibi-
otics and in 21.6% (n= 126) of the cases injections were pre-
scribed. No signiﬁcant difference among the adherence of
prescribers’ with standard treatment guidelines in public and
private healthcare facilities has been observed. The overuse
of injections, antibiotics and lack of adherence of prescribers
to standard treatment regimen clearly reﬂect the lack of knowl-
edge of prescribers regarding national treatment guidelines for
malaria. In none of the cases, dose of anti-malarial drugs were
calculated on body weight. This could be due to the limited
strengths of anti-malarial drugs available in the market which
make it difﬁcult for the prescriber to adhere to the standard
regimen for individual patient based on his/her body weight.
As a result the practitioners prescribe the available brands with
available strengths. Pharmaceutical industry can play its role
more positively in promoting rational drug use by ensuringier B.V. All rights reserved.
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different strengths making it more convenient for the prescrib-
ers to adhere to the standard treatment regimen based on body
weight for individual patient.
Challenge remains, though standard treatment guidelines
are available, but majority of the prescribers do not follow
these protocols (Nizamani et al., 2006). Malaria control pro-
gram ofﬁcials revealed that the reasons for such situation are
the poor integration of malaria control program and its out-
reach, lack of effective training of prescribers on standard
treatment guidelines and poor resource allocation. Political
inﬂuences and lack of involvement of communities their repre-
sentatives and professionals in the policy making are the main
hurdles in effective implementation of standard treatment
guidelines in the country (Khan and Van den Heuvel, 2007).
However a strategic plan of malaria has been made which is
being revised after every ﬁve years. The strategic plan includes
the point that standard treatment guidelines for malaria will be
implemented in the country which will control rational drug
use. Training of standard treatment guidelines by the name
of ‘‘case management training’’ will be conducted. Desk guides
and manuals will be provided and one doctor at every health-
care facility will be trained for three days and later they will
train their staff. In the past, the program was more concerned
regarding getting things functional. But, in the future it will fo-
cus more on quality assurance, extensive and continuous on
job training of prescribers to improve their knowledge and
promote adherence to national treatment guidelines. This will
deﬁnitely increase the capacity of malaria control program
both at central and provincial level to control malaria in the
country.
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